Summary
Benzamide (BA) enhances the cytotoxicity of 1,2:5,6-dianhydrogalactitol (DAG) in resistant P388 leukemia cell lines but not in the sensitive parent line. To examine the reason for this difference in response, we carried out an alkaline elution assay using proteinase K to study DNA interstrand cross-linking. At early time points, equal concentrations of DAG produced the same level of interstrand cross-linking (ICL) in the resistant and sensitive P388 leukemic cells, although marked differences were observed in their cytotoxicity toward the two cell lines. In the sensitive cells, neither the amount of DNA cross-linking nor the cytotoxicity changed during the observation period (38 h) in either the presence or the absence of BA. In contrast, the elution rate of the DNA of DAG-treated resistant cells increased with time and had reached the control levels by 38 h. However, when these cells were postincubated with BA for 38 h, the elution rate of DNA was much faster than that observed for the untreated resistant cells, indicating an accumulation of DNA singlestrand breaks (SSB). The SSB accumulation caused by BA was associated with an inhibition of the activity of ligase II enzyme, which was stimulated when resistant cells were treated with DAG alone. The potentiating effect of BA on the resistant cells can thus be related to the inhibiting action of BA on the DNA-rejoining enzyme, ligase II. The lack of sensitization by BA of the DAG-treated parent cell line may be attributable to the absence of DNA-SSB formation, which is necessary for ligase II activation through the stimulation of poly(ADP-ribose) synthesis.
Similar content being viewed by others
References
Bedford P, Fox BW (1982) Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance. Cancer Chemother Pharmacol 8:3
Bence J, Somfai-Relle S, Gáti E (1986) Development and some characteristics of a P388 leukemia strain resistant to 1,2:5,6-dianhydrogalaction. Eur J Cancer Clin Oncol 22:773
Benjamin RC, Gill DM (1980) ADP-ribosylation in mammalian cell ghosts. J Biol Chem 255:10493
Berger NA, Catino DM, Vietti TJ (1982) Synergistic antileukemia effect of 6-amino-nicotinamide and 1,3-bis(2-chlorethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. Cancer Res 42:4382
Brown DM, Horsman MR, Hirst DG, Brown JM (1984) Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly(ADP-ribose) polymerase. Int J Radiat Oncol Biophys 10:1665
Chen G, Pan QC (1988) Potentiation of antitumor activity of cisplatin in mice by 3-aminobezamide and nicotinamide. Cancer Chemother Pharmacol 22:33
Chen G, Zeller WJ (1990) Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo. Cancer Chemother Pharmacol 26:37
Creissen D, Shall S (1982) Regulation of DNA ligase activity by poly(ADP-ribose). Nature 296:271
Horsman MR, Brown DM, Hirst DG, Brown JM (1986) Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase. Br J Cancer 53:247
Institoris E (1981) In vivo study on alkylation site in DNA by the bifunctional dianhydrogalactitol. chem Biol Interact 35:207
Institoris E, Tamás J (1980) Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine. Biochem J 185:659
Institoris E, Fox BW, Pályi I, Ötvös L (1990) Involvement of DNA ligase II in modification of resistance to bifunctional alkylating agent by benzamide (abstract). J Cancer Res Clin Oncol [Suppl] 116:416
Kawamitsu H, Miwa M, Tanaka Y, Sakamoto H, Terada M, Hoshi A, Sugimura T (1982) Inhibitors of poly(adenosine diphosphate ribose)polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma. J Pharmacol Dyn 5:900
Kohn KW, Spears CL, Doty P (1966) Interstrand crosslinking of DNA by nitrogen mustard. J Mol Biol 19:266
Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and cross-links in DNA by alkaline elution. In: Friedberg EC, Hanawalt PC (eds) DNA repair. A laboratory manual of research procedures, vol I, part B. Marcel Dekker, New York, p 379
Mezzina M, Nocentini S (1978) DNA ligase activity in UV-irradiated monkey kidney cells. Nucleic Acid Res 5:4317
Mezzina M, Sarasin A, Politi N, Bertazzoni U (1984) Heterogeneity of mammalian DNA ligase detected on activity and DNA sequencing gels. Nucleic Acid Res 12:5109
Ohashi Y, Ueda K, Kawaichi M, Hayaiski O (1983) Activation of DNA ligase by poly(ADP-ribose) in chromatin. Proc Natl Acad Sci USA 80:3604
Olivera B (1971) The DNA joining enzyme fromEscherichia coli. Methods enzymol 21:311
Olivera BM, Lehman IR (1968) Enzymic joining of polynucleotide. Polydeoxyadenylate: polydeoxythymidylate homopolymer pair. J Mol Biol 36:261
Pályi I (1986) Survival responses to new cytostatic hexitols of P388 mouse and K562 human leukemia cells in vitro. Cancer Treat Rep 70:279
Pályi I, Bence J, Szikla K, Hullan L (1989) Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactiol in P388 mouse lymphoma hybrid cells. Cancer Chemother Pharmacol 23:41
Söderhall S, Lindahl T (1975) Mammalian DNA ligases. J Biol Chem 250:8438
Söderhall S, Lindahl T (1976) DNA ligases of eukaryotes. FEBS Lett 67:1
Terakoa H, Sumikawa T, Tsukada K (1986) Purification of DNA ligase II from calf thymus and preparation of rabbit antibody against calf thymus DNA ligase II. J Biol Chem 261:6888
Umbach G, Poethen J, Umbach U (1985) Effect of 3-aminobenzamide on the cytotoxicity of cisplatin in human ovarian cancer cell line. Proc Am Assoc Cancer Res 26:26
Yamamoto H, Okamoto H (1982) Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strandbreaks. FEBS Lett 145:298
Yoshihara K, Itaya A, Tanaka Y, Ohashi Y, Ito K, Teraoka H, Tsukada K, Matsukage A, Kamiya T (1985) Inhibition of DNA polymerase α, DNA polymerase β, terminal deoxynucleotidyl transferase, and ligase II by poly(ADP-ribosyl)ation reaction in vitro. Biochem Biophys Res Commun 128:61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Institoris, E., Fox, B.W. & Pályi, I. Benzamide potentiation of the cytotoxicity of bifunctional galacticol in resistant P388 leukemia correlates with inhibition of DNA ligase II. Cancer Chemother. Pharmacol. 30, 325–329 (1992). https://doi.org/10.1007/BF00686304
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686304